Drawing for IDIENCE

USPTO serial 97407950

IDIENCE

Reviewed by CopyMark Law Group

Reg. 7091550Status 700Registered
Filing date
Status date
Registration date
Jun 27, 2023
Examiner
HUTCHISON, DAVID A
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IDIENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael T. Smith

8110 GATEHOUSE ROAD, SUITE 100 EASTFALLS CHURCH, VA 22042UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Research and development of vaccines and medicines; Technical consultancy relating to research services in the field of foods and dietary supplements; Scientific research in the fields of biomedicine; Scientific research in the field of crude medicines; Product development in the field of cell therapy products; Drug discovery services; Development of pharmaceutical preparations and medicines; Research and development in the field of pharmaceutical preparations and biotechnology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Pharmaceutical products development; Inspection of pharmaceuticals; Consultancy in the fields of pharmaceutical research and development; Pharmaceutical research and development; Clinical testing of medicines in the nature of testing of pharmaceuticals; Pharmaceutical drug development services; Medicine research, namely, medical research; Medical research in the field of medical products; Providing information in the fields of testing, inspection, or research of medical products in the nature of pharmaceuticals; Medical and scientific research, namely, conducting clinical trials for othersACTIVEMar 3, 2021

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 27, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 27, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 11, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 11, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 22, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 3, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 3, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Mar 3, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 3, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 3, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 1, 2023DOCKASSIGNED TO EXAMINER—
May 17, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 16, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance